United States Peptide Therapeutics Market with CAGR of 7.8% during 2024-2031 - Exclusive Report by DatamIntelligence

"Peptide Therapeutics Market is expected to grow at a CAGR of 7.8% during the forecast period (2024-2031)." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/peptide-therapeutics-market?sp

United States: Recent Industry Developments

✅ In September 2025, Amgen launched a novel peptide therapeutic targeting metabolic disorders, designed for enhanced stability, bioavailability, and precision receptor modulation to improve patient outcomes.

✅ In August 2025, Eli Lilly expanded clinical trials for peptide-based therapies addressing autoimmune diseases, integrating advanced delivery systems for improved efficacy and safety.

✅ In July 2025, Moderna introduced peptide therapeutics for oncology applications, leveraging mRNA technology to stimulate targeted immune responses and enhance anti-tumor activity.

✅ In June 2025, Pfizer invested in R&D for next-generation peptide therapeutics with extended half-life and tissue-specific targeting, supporting chronic disease management and precision medicine initiatives.

Japan: Recent Industry Developments

✅ In September 2025, Takeda Pharmaceutical launched peptide therapeutics for metabolic and cardiovascular disorders, focusing on stability, targeted delivery, and patient-centric outcomes.

✅ In August 2025, Astellas Pharma expanded its peptide drug portfolio with novel formulations for autoimmune and inflammatory diseases, emphasizing enhanced safety and efficacy.

✅ In July 2025, Daiichi Sankyo introduced peptide-based oncology therapies aimed at precision immune modulation, supporting improved tumor response and patient survival.

✅ In June 2025, Chugai Pharmaceutical invested in R&D for advanced peptide therapeutics using innovative delivery platforms, targeting chronic and rare diseases in Japan.

Peptide Therapeutics Market: Drivers

The peptide therapeutics market is witnessing robust growth, driven by increasing demand for targeted and highly specific therapies across oncology, metabolic disorders, infectious diseases, and cardiovascular conditions. Peptides, due to their high specificity, low toxicity, and favorable pharmacokinetic profiles, are emerging as effective alternatives to traditional small molecules and biologics. Advances in peptide synthesis, modification technologies, and delivery systems are enhancing stability, bioavailability, and therapeutic efficacy. Growing investments in research and development, rising prevalence of chronic and rare diseases, and expanding adoption of precision medicine are further supporting market growth. Increasing regulatory approvals and awareness among healthcare providers and patients are boosting adoption of peptide-based therapies globally.

Leading pharmaceutical and biotechnology companies, including Novo Nordisk, Amgen, Pfizer, and Bachem, are actively developing innovative peptide therapeutics for diverse indications such as diabetes, cancer, and infectious diseases. Research into novel peptide conjugates, oral formulations, and long-acting delivery systems is expanding therapeutic possibilities. Strategic collaborations between biotech firms, academic institutions, and pharmaceutical companies are accelerating clinical development, regulatory approval, and commercialization of advanced peptide therapies. Rising focus on personalized medicine, patient-centric treatment approaches, and unmet medical needs is driving market adoption. With continuous innovation, increasing clinical applications, and growing healthcare awareness, the peptide therapeutics market is poised for sustained global growth.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/peptide-therapeutics-market?sp

Peptide Therapeutics Market: Major Players

Eli Lilly and Company, Amgen Inc., Pfizer Inc., Bristol-Myers Squibb Company, Ever Neuro Pharma GmbH, Takeda Pharmaceutical Company Limited, Teva Pharmaceuticals Industries Ltd, AstraZeneca PLC, GlaxoSmithKline PLC, and Novo Nordisk AS among others.

Segment Covered in the Peptide Therapeutics Market:

➥ By Type: Patented, Generic

➥ By Application: Cancer, Cardiovascular Diseases, Metabolic Diseases, Central Nervous System Disorders, Respiratory Diseases, Infectious Diseases

➥ By Route of Administration: Oral Route, Parenteral Route

➥ By Technology: Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), Hybrid Phase Peptide Synthesis (HPPS)

Research Process:

Both primary and secondary data sources have been used in the Peptide Therapeutics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Peptide Therapeutics Market Research Industry:

➠ Who leads the Peptide Therapeutics industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Peptide Therapeutics market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Peptide Therapeutics market growth?
➠ What are the dominant sales and distribution strategies in the Peptide Therapeutics industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=peptide-therapeutics-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.